Viewing data from:

FLUVOXAMINE MALEATE

ANDA

FLUVOXAMINE MALEATE | A075900 | CHARTWELL RX SCIENCES LLC

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.2453

per ea

Lowest NADAC/Unit

$0.1402

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
62135093330FLUVOXAMINE MALEATE 100 MG TAB	$0.2453	EA	Generic	—	2026-06-17
62135093260FLUVOXAMINE MALEATE 50 MG TAB	$0.2067	EA	Generic	—	2026-06-17
62135093190FLUVOXAMINE MALEATE 25 MG TAB	$0.1402	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain12 active DMFs3 inactive

12 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVFLUVOXAMINE MALEATE

DMF 139131998

MEDICHEM SAFLUVOXAMINE MALEATE

DMF 145111999

APOTEX PHARMACHEM INDIA PVT LTDFLUVOXAMINE MALEATE USP

DMF 145291999

SUN PHARMACEUTICAL INDUSTRIES LTDFLUVOXAMINE MALEATE USP

DMF 161742002

VERANOVA LPFLUVOXAMINE MALEATE (SVB)

DMF 205692007

LONZA AGFLUVOXAMINE MALEATE (SV-006)

DMF 252012011

COHANCE LIFESCIENCES LTDFLUVOXAMINE MALEATE USP

DMF 295822015

DASAMI LAB PRIVATE LTDFLUVOXAMINE MALEATE USP

DMF 363032021

JEWIM PHARMACEUTICAL (SHANDONG) CO LTDFLUVOXAMINE MALEATE

DMF 390192023

ALIVUS LIFE SCIENCES LTDFLUVOXAMINE MALEATE USP

DMF 416102025

SHANDONG RISEN-SUN PHARMACEUTICAL CO LTDFLUVOXAMINE MALEATE

DMF 432652025

AMI LIFESCIENCES PRIVATE LTDFLUVOXAMINE MALEATE

DMF 435472026

VIS FARMACEUTICI INSTITUTO SCIENTIFICO VINEZIE SPAInactiveFLUVOXAMINE MALEATE

DMF 123531997

DIOSYNTH BVInactiveFLUVOXAMINE MALEATE

DMF 138921998

ALKERMES INCInactiveFLUVOXAMINE MALEATE CR CAPSULES

DMF 139571999

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 25MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Feb 23, 2006

No patent or exclusivity listings for this strength.

#002 — 50MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Feb 23, 2006

#003 — 100MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Feb 23, 2006